Jager, E.C.; van Hemel, B.M.; Rutgers, B.; Zandee, W.T.; Jansen, L.; Kruijff, S.; Links, T.P.
Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer. Cancers 2025, 17, 737.
https://doi.org/10.3390/cancers17050737
AMA Style
Jager EC, van Hemel BM, Rutgers B, Zandee WT, Jansen L, Kruijff S, Links TP.
Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer. Cancers. 2025; 17(5):737.
https://doi.org/10.3390/cancers17050737
Chicago/Turabian Style
Jager, Eline C., Bettien M. van Hemel, Bea Rutgers, Wouter T. Zandee, Liesbeth Jansen, Schelto Kruijff, and Thera P. Links.
2025. "Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer" Cancers 17, no. 5: 737.
https://doi.org/10.3390/cancers17050737
APA Style
Jager, E. C., van Hemel, B. M., Rutgers, B., Zandee, W. T., Jansen, L., Kruijff, S., & Links, T. P.
(2025). Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer. Cancers, 17(5), 737.
https://doi.org/10.3390/cancers17050737
